On-demand CE programs From the FDA’s Division of Drug Information

The U.S. Food and Drug Administration’s (FDA) Division of Drug Information* presents… Educational Webinars for Healthcare Professionals FDA’s Division of Drug Information in the Center for Drug Evaluation and Research […]

On-demand CE programs From the FDA’s Division of Drug Information

The U.S. Food and Drug Administration’s (FDA) Division of Drug Information* presents… Educational Webinars for Healthcare Professionals FDA’s Division of Drug Information in the Center for Drug Evaluation and Research […]

On-demand CE programs From the FDA’s Division of Drug Information

The U.S. Food and Drug Administration’s (FDA) Division of Drug Information* presents… Educational Webinars for Healthcare Professionals FDA’s Division of Drug Information in the Center for Drug Evaluation and Research […]

On-demand CE programs From the FDA’s Division of Drug Information

The U.S. Food and Drug Administration’s (FDA) Division of Drug Information* presents… Educational Webinars for Healthcare Professionals FDA’s Division of Drug Information in the Center for Drug Evaluation and Research […]

“Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations”

Nova Biomedical* presents… “Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations” Part I: Clinical Consequences  |  “Venous, arterial, and now capillary specimens are all FDA cleared for testing […]